Angiotensin converting enzyme gene insertion/deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children

Scandinavian Journal of Urology and Nephrology

Volumn 35, Issue 3, 2001, Pages 239-242

  Al Eisa, A ^a   Haider, M Z ^a   Srivastva, B S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

ACE gene; Allele; Nephrotic syndrome; PCR

Indexed keywords

CELL DNA; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; STEROID;

ALLELE; ARAB; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG DEPENDENCE; DRUG SENSITIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; KUWAIT; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KUWAIT; MALE; NEPHROTIC SYNDROME; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0034934290     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655901750292033     Document Type: Article

References (22)

1. Cyclosporin in frequently relapsing minimal change nephrotic syndrome
2. HLA-DQB1 and DRB1 alleles in Egyptian children with steroid sensitive nephrotic syndrome
3. Minimal change nephrotic syndrome and focal segmental glomerulosclerosis
4. Nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis
5. The management of primary glomerular disease: Alternatives to steroid therapy
6. Angiotensin-converting enzyme gene polymorphism in patients with minimal change nephrotic syndrome and focal segmental glomerulosclerosis
7. Angiotensin I converting enzyme in the human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes
8. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels
9. Evidence from combined segregation and linkage analysis that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels
10. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
11. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
12. Angiotensin converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy
13. ACE genotype and progression of IgA nephropathy
14. Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy
15. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
16. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy
17. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase 1)
18. Role of the renin-angiotensin system in disorders of the urinary tract
19. Angiotensin II as a renal growth factor
20. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerulosclerosis
21. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells